3billion is revolutionizing the existing methods and procedures to enable more people to benefit from faster and much accurate diagnosis at an affordable cost.
[Who is 3billion?]
- 3billion provides an AI-driven clinical diagnostic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases for patients and physicians in need.
- 3billion reanalyzes the undiagnosed patients’ genomic data every day without any additional charge. About 10% of undiagnosed patients can receive diagnosis by reanalysis.
- More than 40,000 rare diseases patients from more than 60 countries have been tested.
- More than 93% of acceptance rate on the 3billion’s test report by physicians.
- 3billion has been collaborating with 100 medical institutions across 33 countries to make a diagnosis for rare disease patients.
[Core Technology Features]
- 3billion has expertise in medical genetics. We have streamlined the analysis pipeline using an automated variant prioritization system and are currently leading diagnostic technology by developing a pathogenicity prediction model of human variants.
- 3billion devised a variant interpretation system, EVIDENCE, to automate the process. With the help of EVIDENCE, the variant interpretation takes less than 5 minutes per patient on average.
- The EVIDENCE produces consistent variant interpretation according to the current medical guideline, ACMG-AMP interpretation guideline. 3billion's medical geneticist gives the diagnosis and confirms reported variants by Sanger validation (Richards S et al, 2015).
- The analysis reflects the latest updates on diseases and genetic variants on daily basis. If any diagnosed case is identified through reanalysis, 3billion provides a report without any additional charge.
- We offer Whole Exome Sequencing (WES) & Whole Genome Sequencing (WGS) for rare disease diagnosis.
- Web-based portal service – easy access from all over the world.
For any inquires, please contact us at support@3billion.io
Company Details
- Employees
- 61
- Founded
- -
- Address
- 14th Floor, 416, Teheran-Ro, Gangnam-Gu,seoul 06193,korea, Republic Of
- su****@****lion.io
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- 3billion.io
- Keywords
- Bioinformatics, Genetics, Sequencing, Biotechnology, genetic test, rare disease, diagnostic test, WGS, WES, Whole genome, Whole exome.
- HQ
- Gangnam-gu, Seoul
3billion Questions
3Billion's website is 3billion.io
3Billion's LinkedIn profile is https://kr.linkedin.com/company/3billion
3Billion has
61 employees.
View email and phone details for 61
employees at 3Billion.
3Billion's industry is
Biotechnology Research
3Billion's top competitors are
Bertis Inc,
Heuron,
Deep Bio Inc.,
Lunit Cancer Screening,
Natera,
Standigm,
Macrogen Inc.,
Vuno Inc.,
Centogene,
Gc Biopharma (Gc녹십자).
3Billion's support email address is support@3billion.io
3Billion's categories are Biotechnology Research
3Billion's founding year is 2016
